Cash flow GlaxoSmithKline Pharmaceuticals Limited

Stocks

GLAXO

INE159A01016

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 06:01:12 2026-07-24 EDT			5-day change	1st Jan Change
2,513.25 ^INR	+0.76%		+0.26%	+1.71%

05-29	GlaxoSmithKline Pharmaceuticals Limited Announces Resignation of Dr. Simrat Sohal from Compliance Officer and Ceases to Be the Senior Management Personnel, Effective August 5, 2026	CI
05-13	GlaxoSmithKline Pharmaceuticals Clocks Higher Fiscal Q4 Consolidated Net Profit	MT

6d418724f34f8b101e1d076f39c913.3T8qDwrcgHBt3JSCJFN50zwMKgW8hqy13k108s32lZg.ml4ZV22Q7CU86f_rEWoMvQtEbnHTq-fns3U9sbqZp_uLZh5fY6W1Ny_loA

Published financial data: GLAXOSMITHKLINE PHARMACEUTICALS LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2022	2023	2024	2025	2026
Revenues	32.78B	32.52B	34.54B	37.49B	38.22B
Total Revenues	32.78B	32.52B	34.54B	37.49B	38.22B
Cost of Goods Sold, Total	13.78B	13.04B	13.55B	14.14B	13.76B
Gross Profit	19B	19.48B	20.99B	23.35B	24.46B
Selling General & Admin Expenses, Total	7.4B	7.06B	7.36B	7.02B	7.37B
Depreciation & Amortization - (IS)	682M	658M	697M	668M	664M
Other Operating Expenses	3.92B	4.27B	4.54B	4.52B	3.95B
Other Operating Expenses, Total	12.01B	11.99B	12.59B	12.21B	11.98B
Operating Income	6.99B	7.48B	8.39B	11.14B	12.48B
Interest Expense, Total	-19.96M	-18.12M	-17.99M	-13.14M	-27.32M
Interest And Investment Income	717M	698M	729M	763M	657M
Net Interest Expenses	697M	680M	711M	750M	630M
Currency Exchange Gains (Loss)	-51.36M	-99.07M	-	-22.66M	-47.64M
Other Non Operating Income (Expenses)	37M	428K	-	-	-
EBT, Excl. Unusual Items	7.67B	8.07B	9.1B	11.87B	13.06B
Restructuring Charges	-201M	-114M	-1.63B	-	-
Gain (Loss) On Sale Of Investments	-	308M	488M	696M	796M
Gain (Loss) On Sale Of Assets	3.24M	278K	8.89M	-15.13M	-457K
Asset Writedown	2.61M	-	-	-	-
Legal Settlements	-	-	-	-	-
Other Unusual Items	314M	104M	197M	46.92M	206M
EBT, Incl. Unusual Items	7.79B	8.36B	8.16B	12.6B	14.06B
Income Tax Expense	3.98B	2.29B	2.26B	3.32B	3.7B
Earnings From Continuing Operations	3.81B	6.08B	5.9B	9.28B	10.36B
Earnings Of Discontinued Operations	13.14B	30.45M	-	-	-
Net Income to Company	16.95B	6.11B	5.9B	9.28B	10.36B
Net Income - (IS)	16.95B	6.11B	5.9B	9.28B	10.36B
Net Income to Common Incl Extra Items	16.95B	6.11B	5.9B	9.28B	10.36B
Net Income to Common Excl. Extra Items	3.81B	6.08B	5.9B	9.28B	10.36B
Per Share Items
Net EPS - Basic	100.04	36.05	34.83	54.76	61.15
Basic EPS - Continuing Operations	22.48	35.87	34.83	54.76	61.15
Basic Weighted Average Shares Outstanding	169M	169M	169M	169M	169M
Net EPS - Diluted	100.04	36.05	34.83	54.76	61.15
Diluted EPS - Continuing Operations	22.48	35.87	34.83	54.76	61.15
Diluted Weighted Average Shares Outstanding	169M	169M	169M	169M	169M
Normalized Basic EPS	28.3	29.76	33.58	43.79	48.18
Normalized Diluted EPS	28.3	29.76	33.58	43.79	48.18
Dividend Per Share	30	32	32	42	57
Payout Ratio	29.89	249.8	91.8	80.79	68.92
Supplemental Items
EBITDA	7.43B	7.88B	8.81B	11.53B	12.86B
EBITA	6.99B	7.48B	8.39B	11.14B	12.48B
EBIT	6.99B	7.48B	8.39B	11.14B	12.48B
EBITDAR	7.45B	7.9B	8.83B	11.55B	12.88B
Total Revenues (As Reported)	33.54B	33.52B	35.76B	38.95B	-
Effective Tax Rate - (Ratio)	51.12	27.35	27.72	26.38	26.32
Total Current Taxes	4.08B	2.47B	2.38B	3.26B	3.61B
Total Deferred Taxes	-94.01M	-184M	-114M	63.39M	94.57M
Normalized Net Income	4.79B	5.04B	5.69B	7.42B	8.16B
Interest on Long-Term Debt	17.37M	13.98M	15.75M	11.79M	27.22M
Non-Cash Pension Expense	7.58M	8.24M	-1.08M	-3.32M	112M
Supplemental Operating Expense Items
Advertising Expense	1.28B	1.09B	1.09B	1.2B	1.28B
Selling and Marketing Expenses	1.28B	1.09B	1.09B	1.2B	1.28B
Research And Development Expense From Footnotes	18.28M	19.1M	25.44M	26.12M	32.2M
Net Rental Expense, Total	18.13M	20.98M	20.05M	19.77M	19.81M
Imputed Operating Lease Interest Expense	10.58M	17.08M	16.87M	14.52M	20.04M
Imputed Operating Lease Depreciation	7.54M	3.9M	3.18M	5.25M	-226K
Maintenance & Repair Expenses, Total	220M	192M	207M	230M	246M
Stock-Based Comp., SG&A Exp. (Total)	65.45M	25.33M	114M	81.98M	124M
Stock-Based Comp., Other (Total)	-	-	-	-	-
Total Stock-Based Compensation	65.45M	25.33M	114M	81.98M	124M

Fiscal Period: March	2022	2023	2024	2025	2026
Assets
Cash And Equivalents	2.86B	349M	642M	5.39B	11.02B
Short Term Investments	21.79B	11.01B	9.79B	8.41B	2.64B
Trading Asset Securities, Total	3.66B	5.18B	8.13B	11.18B	13.91B
Total Cash And Short Term Investments	28.31B	16.54B	18.57B	24.98B	27.57B
Accounts Receivable, Total	2.05B	1.92B	2.22B	2.93B	2.73B
Other Receivables	715M	1.37B	1.28B	683M	345M
Notes Receivable	-	-	-	-	-
Total Receivables	2.77B	3.3B	3.5B	3.61B	3.08B
Inventory	5.35B	4.6B	5.25B	4.82B	4.58B
Prepaid Expenses	139M	150M	206M	189M	191M
Restricted Cash	-	-	-	-	-
Other Current Assets, Total	518M	355M	463M	503M	651M
Total Current Assets	37.08B	24.94B	27.98B	34.1B	36.06B
Gross Property Plant And Equipment	5.48B	5.71B	5.94B	5.79B	6.26B
Accumulated Depreciation	-2.23B	-2.56B	-2.83B	-2.96B	-3.2B
Net Property Plant And Equipment	3.25B	3.15B	3.11B	2.84B	3.06B
Long-term Investments	145K	265K	265K	265K	8.93M
Other Intangibles, Total	345M	341M	236M	133M	65.56M
Loans Receivable Long-Term	1.9B	700M	-	-	-
Deferred Tax Assets Long-Term	1.13B	1.34B	1.46B	1.41B	1.34B
Other Long-Term Assets, Total	2.62B	2.8B	2.78B	2.6B	2.7B
Total Assets	46.33B	33.27B	35.57B	41.08B	43.24B
Liabilities
Accounts Payable, Total	5.71B	4.28B	6.25B	7.08B	5.7B
Accrued Expenses, Total	4.62B	1.48B	1.65B	2.22B	1.52B
Current Portion of Long-Term Debt	-	-	-	-	-
Current Portion of Leases	125M	121M	122M	74.59M	160M
Current Income Taxes Payable	2.96B	2.96B	2.99B	5.25B	5.46B
Unearned Revenue Current, Total	-	-	-	-	-
Other Current Liabilities	3.57B	4.42B	4.23B	4.43B	4.95B
Total Current Liabilities	16.98B	13.26B	15.25B	19.05B	17.79B
Long-Term Debt	-	-	-	-	-
Long-Term Leases	76.24M	34.55M	64.69M	24.92M	173M
Pension & Other Post Retirement Benefits	795M	794M	803M	868M	787M
Other Non Current Liabilities	1.85B	1.76B	1.67B	1.62B	1.81B
Total Liabilities	19.7B	15.85B	17.79B	21.57B	20.56B
Common Stock, Total	1.69B	1.69B	1.69B	1.69B	1.69B
Retained Earnings	25.21B	16.07B	16.35B	18.37B	21.62B
Comprehensive Income and Other	-275M	-352M	-269M	-552M	-636M
Total Common Equity	26.63B	17.41B	17.78B	19.51B	22.67B
Total Equity	26.63B	17.41B	17.78B	19.51B	22.67B
Total Liabilities And Equity	46.33B	33.27B	35.57B	41.08B	43.24B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	169M	169M	169M	169M	169M
ECS Total Common Shares Outstanding	169M	169M	169M	169M	169M
Book Value / Share	157.19	102.79	104.93	115.19	133.85
Tangible Book Value	26.28B	17.07B	17.54B	19.38B	22.61B
Tangible Book Value Per Share	155.16	100.77	103.54	114.4	133.46
Total Debt	201M	155M	187M	99.51M	333M
Net Debt	-28.11B	-16.39B	-18.38B	-24.88B	-27.24B
Debt Equivalent of Unfunded Proj. Benefit Obligation	177M	45.63M	-6.1M	21.43M	39.83M
Debt Equivalent Oper. Leases	145M	168M	160M	158M	159M
Equity Method Investments, Total	-	-	-	-	8.67M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	1.07B	1.06B	1.07B	1.13B	930M
Inventories - Work In Process, Total	8.76M	9.52M	8.07M	9.42M	15.59M
Inventories - Finished Goods, Total	4.23B	3.49B	4.13B	3.67B	3.62B
Inventories - Others	38.82M	38.5M	40.01M	8.46M	10.98M
Land - (BS)	22.49M	37M	36.8M	37M	37M
Buildings, Total	1.04B	1.08B	1.1B	1.12B	1.14B
Machinery, Total	3.94B	4.24B	4.49B	4.4B	4.44B
Full Time Employees	3.84K	3.68K	3.21K	3.11K	3.1K
Accumulated Allowance for Doubtful Accounts (Supple)	202M	129M	135M	158M	177M

Fiscal Period: March	2022	2023	2024	2025	2026
Net Income	16.95B	6.11B	5.9B	9.28B	10.36B
Depreciation & Amortization - CF	587M	561M	591M	566M	597M
Depreciation & Amortization, Total	587M	561M	591M	566M	597M
Amortization of Deferred Charges, Total - (CF)	94.7M	96.94M	105M	102M	67.75M
(Gain) Loss From Sale Of Asset	-3.24M	-278K	-8.89M	15.13M	457K
(Gain) Loss on Sale of Investments - (CF)	-	-308M	-488M	-696M	-796M
Provision and Write-off of Bad Debts	1.62M	-73.64M	5.87M	23.76M	18.86M
Net Cash From Discontinued Operations	729M	41.26M	-	-	-
Other Operating Activities, Total	-11.45B	-1.12B	-896M	1.76B	-233M
Change In Accounts Receivable	102M	202M	-303M	-729M	176M
Change In Inventories	120M	747M	-651M	433M	242M
Change In Accounts Payable	1.02B	-1.53B	1.9B	770M	-1.39B
Change in Other Net Operating Assets	-47.1M	125M	-338M	1.37B	-10.45M
Cash from Operations	8.11B	4.84B	5.82B	12.9B	9.03B
Capital Expenditure	-346M	-440M	-312M	-230M	-553M
Sale of Property, Plant, and Equipment	11.77M	14.56M	44.69M	57.17M	220M
Sale (Purchase) of Real Estate properties	323M	97.8M	197M	-	-
Investment in Marketable and Equity Securities, Total	-18.12B	9.56B	-1.45B	-1.44B	3.17B
Other Investing Activities, Total	14.08B	-1.16B	1.61B	1.16B	1.13B
Cash from Investing	-4.06B	8.08B	87.12M	-458M	3.97B
Long-Term Debt Repaid, Total	-156M	-169M	-181M	-187M	-204M
Total Debt Repaid	-156M	-169M	-181M	-187M	-204M
Common Dividends Paid	-5.07B	-15.25B	-5.42B	-7.49B	-7.14B
Common & Preferred Stock Dividends Paid	-5.07B	-15.25B	-5.42B	-7.49B	-7.14B
Other Financing Activities, Total	-19.9M	-9.55M	-17.99M	-13.14M	-27.32M
Cash from Financing	-5.24B	-15.43B	-5.61B	-7.69B	-7.37B
Net Change in Cash	-1.19B	-2.51B	292M	4.75B	5.63B
Supplemental Items
Cash Interest Paid	19.9M	13.98M	15.75M	13.14M	27.32M
Cash Income Tax Paid (Refund)	1.19B	2.65B	2.35B	824M	3.22B
Levered Free Cash Flow	10.1B	1.56B	6.7B	11.62B	7.29B
Unlevered Free Cash Flow	10.11B	1.57B	6.71B	11.63B	7.31B
Change In Net Working Capital	-5.34B	3.35B	-970M	-4.15B	722M
Net Debt Issued / Repaid	-156M	-169M	-181M	-187M	-204M

Fiscal Period: March	2022	2023	2024	2025	2026
Profitability
Return on Assets	11.27	11.75	15.24	18.17	18.49
Return on Total Capital	20.82	21.07	29.52	37.07	36.59
Return On Equity %	18.39	27.59	33.53	49.75	49.11
Return on Common Equity	18.39	27.59	33.53	49.75	49.11
Margin Analysis
Gross Profit Margin %	57.96	59.89	60.76	62.29	64
SG&A Margin	22.59	21.72	21.3	18.72	19.29
EBITDA Margin %	22.66	24.25	25.5	30.75	33.65
EBITA Margin %	21.32	23.02	24.29	29.72	32.64
EBIT Margin %	21.32	23.02	24.29	29.72	32.64
Income From Continuing Operations Margin %	11.62	18.69	17.08	24.74	27.11
Net Income Margin %	51.7	18.78	17.08	24.74	27.11
Net Avail. For Common Margin %	11.62	18.69	17.08	24.74	27.11
Normalized Net Income Margin	14.63	15.5	16.47	19.79	21.36
Levered Free Cash Flow Margin	30.8	4.8	19.4	31	19.08
Unlevered Free Cash Flow Margin	30.84	4.84	19.44	31.03	19.13
Asset Turnover
Asset Turnover	0.85	0.82	1	0.98	0.91
Fixed Assets Turnover	9.63	10.15	11.04	12.61	12.95
Receivables Turnover (Average Receivables)	15.58	16.36	16.67	14.57	13.51
Inventory Turnover (Average Inventory)	2.55	2.62	2.75	2.81	2.93
Short Term Liquidity
Current Ratio	2.18	1.88	1.84	1.79	2.03
Quick Ratio	1.83	1.5	1.45	1.5	1.72
Operating Cash Flow to Current Liabilities	0.48	0.37	0.38	0.68	0.51
Days Sales Outstanding (Average Receivables)	23.43	22.32	21.96	25.05	27.01
Days Outstanding Inventory (Average Inventory)	143.2	139.19	133.01	129.96	124.61
Average Days Payable Outstanding	138.48	149.5	135.7	177.59	172.65
Cash Conversion Cycle (Average Days)	28.14	12.01	19.27	-22.58	-21.02
Long Term Solvency
Total Debt/Equity	0.75	0.89	1.05	0.51	1.47
Total Debt / Total Capital	0.75	0.88	1.04	0.51	1.45
LT Debt/Equity	0.29	0.2	0.36	0.13	0.76
Long-Term Debt / Total Capital	0.28	0.2	0.36	0.13	0.75
Total Liabilities / Total Assets	42.53	47.66	50.02	52.5	47.56
EBIT / Interest Expense	350.1	412.99	466.45	848.25	456.6
EBITDA / Interest Expense	379.52	443.94	499.33	891.31	478.44
(EBITDA - Capex) / Interest Expense	362.16	419.63	481.98	873.79	458.21
Total Debt / EBITDA	0.03	0.02	0.02	0.01	0.03
Net Debt / EBITDA	-3.71	-2.04	-2.05	-2.12	-2.08
Total Debt / (EBITDA - Capex)	0.03	0.02	0.02	0.01	0.03
Net Debt / (EBITDA - Capex)	-3.89	-2.15	-2.12	-2.17	-2.18
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	12.05	-0.8	6.21	8.56	1.93
Gross Profit, 1 Yr. Growth %	15.61	2.52	7.75	11.29	4.74
EBITDA, 1 Yr. Growth %	29.56	6.14	11.69	30.91	11.57
EBITA, 1 Yr. Growth %	34.5	7.1	12.1	32.82	11.95
EBIT, 1 Yr. Growth %	34.5	7.1	12.1	32.82	11.95
Earnings From Cont. Operations, 1 Yr. Growth %	32.55	59.58	-2.91	57.23	11.69
Net Income, 1 Yr. Growth %	373.19	-63.97	-3.39	57.23	11.69
Normalized Net Income, 1 Yr. Growth %	22.42	5.22	12.84	30.43	10
Diluted EPS Before Extra, 1 Yr. Growth %	32.55	59.58	-2.91	57.23	11.69
Accounts Receivable, 1 Yr. Growth %	-4.81	-6.27	15.43	31.74	-6.64
Inventory, 1 Yr. Growth %	-2.2	-13.98	14.15	-8.25	-5.02
Net Property, Plant and Equip., 1 Yr. Growth %	-8.43	-3.17	-1.39	-8.65	7.96
Total Assets, 1 Yr. Growth %	48.76	-28.2	6.91	15.5	5.25
Tangible Book Value, 1 Yr. Growth %	83.18	-35.05	2.75	10.48	16.66
Common Equity, 1 Yr. Growth %	80.14	-34.61	2.09	9.77	16.2
Cash From Operations, 1 Yr. Growth %	40.29	-40.27	20.2	121.63	-29.97
Capital Expenditures, 1 Yr. Growth %	-21.67	27.13	-29.11	-26.26	140.12
Levered Free Cash Flow, 1 Yr. Growth %	187.98	-84.53	328.98	73.46	-37.25
Unlevered Free Cash Flow, 1 Yr. Growth %	186.53	-84.44	326.6	73.29	-37.15
Dividend Per Share, 1 Yr. Growth %	0	6.67	0	31.25	35.71
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	0.83	5.43	2.64	7.38	5.19
Gross Profit, 2 Yr. CAGR %	0.01	8.87	5.1	9.5	7.96
EBITDA, 2 Yr. CAGR %	7.49	17.27	8.88	20.92	20.85
EBITA, 2 Yr. CAGR %	9.12	20.02	9.57	22.02	21.94
EBIT, 2 Yr. CAGR %	9.12	20.02	9.57	22.02	21.94
Earnings From Cont. Operations, 2 Yr. CAGR %	102.12	45.44	24.47	23.55	32.51
Net Income, 2 Yr. CAGR %	326.41	30.58	-41	23.24	32.51
Normalized Net Income, 2 Yr. CAGR %	9.11	13.45	8.96	21.32	19.78
Diluted EPS Before Extra, 2 Yr. CAGR %	102.12	45.44	24.47	23.55	32.51
Accounts Receivable, 2 Yr. CAGR %	43.4	-5.54	4.02	23.32	10.9
Inventory, 2 Yr. CAGR %	5.21	-8.27	-0.91	2.34	-6.65
Net Property, Plant and Equip., 2 Yr. CAGR %	-37.27	-5.84	-2.29	-5.09	-0.69
Total Assets, 2 Yr. CAGR %	21.6	3.35	-12.39	11.13	10.26
Tangible Book Value, 2 Yr. CAGR %	21.83	9.08	-18.31	6.55	13.53
Common Equity, 2 Yr. CAGR %	20.94	8.53	-18.3	5.86	12.94
Cash From Operations, 2 Yr. CAGR %	28.57	-8.46	-15.27	63.21	24.58
Capital Expenditures, 2 Yr. CAGR %	-52.86	-0.21	-5.06	-27.7	33.06
Levered Free Cash Flow, 2 Yr. CAGR %	1.39K	-33.25	-18.53	172.78	4.32
Unlevered Free Cash Flow, 2 Yr. CAGR %	990.47	-33.22	-18.51	171.89	4.36
Dividend Per Share, 2 Yr. CAGR %	22.47	3.28	3.28	14.56	33.46
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	1.57	0.28	5.69	4.58	5.53
Gross Profit, 3 Yr. CAGR %	2.79	0.84	8.49	7.12	7.89
EBITDA, 3 Yr. CAGR %	7.62	7.04	15.38	15.78	17.72
EBITA, 3 Yr. CAGR %	7.85	8.44	17.32	16.83	18.57
EBIT, 3 Yr. CAGR %	7.85	8.44	17.32	16.83	18.57
Earnings From Cont. Operations, 3 Yr. CAGR %	-5.09	86.81	27.11	34.55	19.46
Net Income, 3 Yr. CAGR %	56.12	87.12	18.1	-18.2	19.26
Normalized Net Income, 3 Yr. CAGR %	6.82	7.77	13.25	15.69	17.42
Diluted EPS Before Extra, 3 Yr. CAGR %	-5.09	86.81	27.11	34.55	19.46
Accounts Receivable, 3 Yr. CAGR %	19.43	24.45	0.99	12.54	12.39
Inventory, 3 Yr. CAGR %	3.2	-1.62	-1.34	-3.42	-0.18
Net Property, Plant and Equip., 3 Yr. CAGR %	-38.02	-27.51	-4.38	-4.46	-0.93
Total Assets, 3 Yr. CAGR %	5.81	2.02	4.52	-3.93	9.13
Tangible Book Value, 3 Yr. CAGR %	8.21	-1.22	6.92	-9.66	9.82
Common Equity, 3 Yr. CAGR %	7.56	-1.47	6.34	-9.85	9.2
Cash From Operations, 3 Yr. CAGR %	25.57	-0.43	0.24	16.74	23.1
Capital Expenditures, 3 Yr. CAGR %	-50.82	-34.39	-10.96	-12.73	7.87
Levered Free Cash Flow, 3 Yr. CAGR %	258.31	225.21	24.1	4.81	67.14
Unlevered Free Cash Flow, 3 Yr. CAGR %	256.59	164.52	23.91	4.79	66.86
Dividend Per Share, 3 Yr. CAGR %	14.47	16.96	2.17	11.87	21.22
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	2.42	2.52	2	3.06	5.49
Gross Profit, 5 Yr. CAGR %	4.94	3.85	3.71	4.22	8.28
EBITDA, 5 Yr. CAGR %	12.09	9.05	8.12	12.39	17.54
EBITA, 5 Yr. CAGR %	12.18	9.42	8.54	13.68	19.15
EBIT, 5 Yr. CAGR %	12.18	9.42	8.54	13.68	19.15
Earnings From Cont. Operations, 5 Yr. CAGR %	2.48	11.62	5.78	58.34	29.24
Net Income, 5 Yr. CAGR %	38.15	11.73	5.78	58.34	23.67
Normalized Net Income, 5 Yr. CAGR %	10.52	8.98	7.65	12.99	15.82
Diluted EPS Before Extra, 5 Yr. CAGR %	2.48	11.62	5.78	58.34	29.24
Accounts Receivable, 5 Yr. CAGR %	3.74	5.53	13.01	24	4.84
Inventory, 5 Yr. CAGR %	4.66	-1.66	1.54	-0.05	-3.5
Net Property, Plant and Equip., 5 Yr. CAGR %	-16.99	-23.12	-25.64	-19.26	-2.92
Total Assets, 5 Yr. CAGR %	9.05	-3.36	-1.88	5.57	6.78
Tangible Book Value, 5 Yr. CAGR %	5.89	-2.97	-3.3	1.82	9.52
Common Equity, 5 Yr. CAGR %	5.82	-3.28	-3.64	1.4	8.93
Cash From Operations, 5 Yr. CAGR %	28.17	0.48	7.28	21.33	9.34
Capital Expenditures, 5 Yr. CAGR %	-35.25	-35.79	-36.02	-31.79	4.56
Levered Free Cash Flow, 5 Yr. CAGR %	52.43	-25.96	98.13	203.13	15.78
Unlevered Free Cash Flow, 5 Yr. CAGR %	52.43	-25.86	97.58	167.44	15.69
Dividend Per Share, 5 Yr. CAGR %	14.87	12.83	9.86	16	13.7